Paper · 14575972
Genetic cause of hyperglycaemia and response to treatment in diabetes.
Pearson ER and 5 others. Lancet, 2003. Cited by 423 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Genetic cause of hyperglycaemia and response to treatment in diabetes. Papers, record 14575972. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/14575972
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't
- PubMed
Topics25
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| DNA-Binding Proteins | Major topic |
| Diabetes Mellitus | Major topic |
| Gliclazide | Major topic |
| Hyperglycemia | Major topic |
| Hypoglycemic Agents | Major topic |
| Metformin | Major topic |
| Nuclear Proteins | Major topic |
| Potassium Channels, Inwardly Rectifying | Major topic |
| Transcription Factors | Major topic |
| ATP-Binding Cassette Transporters | |
| Adult | |
| Aged | |
| Blood Glucose | |
| Diabetes Mellitus, Type 2 | |
| Fasting | |
| Female | |
| Hepatocyte Nuclear Factor 1 | |
| Hepatocyte Nuclear Factor 1-alpha | |
| Hepatocyte Nuclear Factor 1-beta | |
| Humans | |
| Male | |
| Middle Aged | |
| Potassium Channels | |
| Receptors, Drug | |
| Sulfonylurea Receptors |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT01238380 | Using Pharmacogenetics to Improve Treatment in Early-onset Diabetes | Background |
Source ClinicalTrials.gov
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References0
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
None in this release.
Cited by225
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 423 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,747,450 | The management of type 1 diabetes in adults. The updated 2026 consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). | Diabetologia | 2026 | https://conductscience.org/library/papers/42747450 | PubMed |
| 42,681,821 | Genetic and Clinical Determinants of Variation in Drug Response in Type 2 Diabetes: Insights From the Scottish and UK Biobank Cohorts. | Diabetes Obes Metab | 2026 | https://conductscience.org/library/papers/42681821 | PubMed |
| 42,597,412 | Evaluating the use of GLP-1 receptor agonists in Wolfram syndrome patients. | Front Endocrinol (Lausanne) | 2026 | https://conductscience.org/library/papers/42597412 | PubMed |
| 42,488,688 | Health Disparities Among Hispanic Patients With Type 2 Diabetes in the United States: An Educational Workshop. | MedEdPORTAL | 2026 | https://conductscience.org/library/papers/42488688 | PubMed |
| 42,470,517 | Genetic spectrum and treatment implications of maturity-onset diabetes of the young in the eastern Black Sea region of Türkiye: a combined adult and pediatric cohort of 296 patients with identification of rare and novel variants. | Mol Biol Rep | 2026 | https://conductscience.org/library/papers/42470517 | PubMed |
| 42,162,477 | [Genetic, endocrine, drug-induced and pancreatogenic forms of diabetes and exocrine pancreatic insufficiency (Update 2026)]. | Wien Klin Wochenschr | 2026 | https://conductscience.org/library/papers/42162477 | PubMed |
| 42,019,957 | Digenic HNF1A and ABCC8 variants provide mechanistic insight into early-onset diabetes. | J Clin Endocrinol Metab | 2026 | https://conductscience.org/library/papers/42019957 | PubMed |
| 41,987,393 | Insights from maturity-onset diabetes of the young into impaired insulin secretion in type 2 diabetes. | Endocr J | 2026 | https://conductscience.org/library/papers/41987393 | PubMed |
| 41,959,758 | Evaluating the Use of GLP-1 Receptor Agonists in Wolfram syndrome Patients. | medRxiv | 2026 | https://conductscience.org/library/papers/41959758 | PubMed |
| 41,733,136 | High prevalence of maturity-onset diabetes of the young in the Czech Republic: A 25-year nationwide registry-based study. | Diabet Med | 2026 | https://conductscience.org/library/papers/41733136 | PubMed |
1 to 10 of 225
See all 225 cited byGenes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| HNF1A | 6,927 | PubTator's text mining | https://conductscience.org/library/genes/6927 | NCBI Gene |
| HNF1B | 6,928 | PubTator's text mining | https://conductscience.org/library/genes/6928 | NCBI Gene |
| INS | 3,630 | PubTator's text mining | https://conductscience.org/library/genes/3630 | NCBI Gene |
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/14575972
GET https://conductscience.org/api/papers/v1/14575972/cited_by?page=2